Tyler Jacks, Cancer Moonshot Panel Co-Chair, Discusses Roadmap
Xconomy
SEPTEMBER 9, 2016
This week, a panel of 28 scientists presented the National Cancer Institute’s National Cancer Advisory Board a set of recommendations and national priorities for basic research, clinical trial practice, and drug development. Is this akin to a nationwide study, like the government’s precision medicine initiative ?
Let's personalize your content